We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Siemens Healthineers Launches Thermocycler with AI-Powered Software

By LabMedica International staff writers
Posted on 26 Apr 2018
Print article
Image: The FastFinder software is designed to improve workflow using AI-powered automation (Photo courtesy of Siemens Healthcare).
Image: The FastFinder software is designed to improve workflow using AI-powered automation (Photo courtesy of Siemens Healthcare).
Siemens Healthineers (Erlangen, Germany) launched a new molecular thermocycler, the Fast Track cycler (FTC), and the complementary new FastFinder software at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018). The compact FTC allows laboratories of all sizes to implement molecular testing with simplicity and speed, while the FastFinder software improves workflow using Artificial Intelligence (AI)-powered automation.

Weighing two kilograms and measuring 150 mm x 150 mm x 130 mm, the FTC is a scalable platform, allowing up to 10 thermocyclers to be connected to one computer and permitting laboratories to utilize a range of 1 to 480 wells. The FTC uses magnetic induction technology to deliver robust and reliable results, and does not require calibration, as a result of which it does not drift or age and offers simple handling. The FTC is also equipped with the Fast Track lyophilised technology, offering reagents for PCR experiments in a single sample tube, simplifying processes for users by eliminating the need to prepare the reaction mix before test implementation. The technology allows users to simply add nucleic acid extracts to the prepared tubes before inserting into the cycler.

Siemens Healthineers, in collaboration with UgenTec, also launched FastFinder software, which is a fully automated real-time PCR interpretation platform that is compatible with all multiplexing kits from Fast Track Diagnostics. The software allows users to fully automate and standardize analysis of kits with the Applied Biosystems 7500 and LightCycler 480 PCR platforms. FastFinder uses its built-in statistical machine learning models to accurately analyze every amplification curve, then automatically combines these results and processes them through an assay-specific decision tree, leading to overall and conclusive results.

With automated plate detection, Laboratory Information Management System (LIMS) connection, and a user-friendly interface, FastFinder is easy-to-use and requires limited training. All assay parameters come pre-set for speed and ease of implementation, and clear, customizable reports allow easy reading of results. The audit trail of analysis, integrated archive, and simultaneous analysis of multiple run files results in improved monitoring and enables users to provide patients with the relevant treatment more quickly.

“Enabled by AI, FastFinder software minimizes the need for manual processing, which not only saves time, but increases the reliability of results as well,” said Fernando Beils, Head of Molecular Diagnostics, Siemens Healthineers. “Users receive 100% reproducible results in a matter of seconds, improving laboratory workflows and expanding precision medicine."

"Siemens Healthineers' focus on AI aligns perfectly with our vision for FastFinder. The combination of Siemens Healthineers' hardware and assays and our extensible software will guide laboratories globally to simple, accurate, and automated molecular diagnostics," said Steven Verhoeven, CEO at UgenTec.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The QIAstat-Dx Respiratory Panel Plus has received U.S. FDA clearance (Photo courtesy of QIAGEN)

New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results

Respiratory tract infections are a major reason for emergency department visits and hospitalizations. According to the CDC, the U.S. sees up to 41 million influenza cases annually, resulting in several... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more